U.S. Basic Materials Stock News

Exelon Corporation ( NASDAQ:EXC ) shareholders are probably feeling a little disappointed, since its shares fell 3.6...

FAA certification of the Boeing 737 Max 7 has turned a long running uncertainty into a fresh catalyst for Boeing stock and for companies tied to its commercial programs. Aircraft can now move from order books toward delivery, which affects revenue timing, capacity planning, and sentiment around aviation demand. For investors, this news is less about one headline move and more about how it ripples through suppliers and airlines exposed to Boeing’s production ramp up. The sections that follow...

Oil markets are caught between real supply risks and shifting headlines. Shipping routes through the Middle East face their toughest security backdrop since the start of the Iran conflict, yet crude prices have retreated after talk of possible US Iran dialogue. For investors in oil and gas producers, that mix can create sharp moves in both directions. This article focuses on how that news backdrop connects to a curated Energy Sector screener and highlights three stocks that meet the criteria...

Cimpress earnings spark fresh look at the stock Cimpress (CMPR) reported fourth quarter and full year 2026 results on July 29, highlighted by higher sales and a shift from loss to profit, which is likely to refocus investor attention. See our latest analysis for Cimpress. The earnings release has arrived after a strong run in Cimpress, with a year-to-date share price return of 50.32% and a 1-year total shareholder return of 85.56%. Shorter-term moves, such as the 1-day share price return of...

Werner Enterprises, Inc. previously reported second-quarter 2026 results showing sales rising to US$933.93 million from US$753.15 million a year earlier, while net income fell to US$6.35 million from US$44.06 million and diluted EPS from continuing operations dropped to US$0.11 from US$0.72. Despite higher revenue for both the quarter and first half of 2026, Werner’s sharply reduced profitability and effectively inactive buyback program highlight rising pressure on earnings quality and...

Why Republic Bancorp’s latest earnings matter for investors Republic Bancorp (RBCA.A) is back in focus after its second quarter earnings on July 24, 2026, reporting net interest income of US$81.7 million and net income of US$32.87 million for the period. The report also outlined six-month figures to June 30, 2026, along with recent leadership changes inside the Republic Processing Group, giving investors fresh information to reassess the stock’s recent share price performance. See our latest...

Apple’s clash with the UK government over access to encrypted iCloud backups has pushed data privacy and cybersecurity back into the spotlight for investors. As regulators press harder on encryption and cross border data rules, some cybersecurity stocks exposed to this news look better placed than others. This article focuses on three stocks from a Cybersecurity Stocks screener that appear positively exposed to the current debate around privacy standards and regulatory scrutiny. You will see...

In late July 2026, Booz Allen Hamilton expanded its Vellox AI-powered cyber defense suite with Vellox Ranger, an agentic AI tool that automates environment-specific threat detection, while also reporting first-quarter fiscal 2027 results showing sales of US$2,800 million and net income of US$198 million, alongside continued dividends and share repurchases. Together with a new universal shelf registration and a broadened lineup of AI-driven cyber products, these developments highlight Booz...

SpaceX’s steep share price fall, heavy short selling and the pressure around its first earnings report have pushed downside protection and hedging tools into the spotlight. When a company with more than $500b in market cap wiped off experiences this kind of volatility, investors often look beyond the headline stock and toward products that can help manage risk or express a cautious view. This article walks through 3 stocks from a Short Sellers and Downside Protection Strategies screener that...

BankUnited, Inc. reported second-quarter 2026 results showing net interest income of US$255.33 million and net income of US$70.66 million, both modestly higher than a year earlier, with diluted EPS from continuing operations rising to US$0.97. Alongside this earnings improvement, the bank’s net charge-offs roughly halved to US$6.37 million and it completed a US$154.18 million buyback retiring 4.68% of its shares, underscoring management’s focus on credit quality and capital returns. We’ll...

Geopolitics, oil prices and interest rate expectations just collided in a way that puts US airlines and travel stocks back in focus. President Trump’s decision to cancel planned strikes on Iran eased conflict risks, helped pull oil sharply lower and coincided with a strong move in the Dow, S&P 500 and Nasdaq. That mix can quickly reshape expectations for fuel costs, demand and risk appetite. This article walks through 3 US airlines and travel stocks exposed to this news, explaining why some...

10x Genomics (TXG) stock is in focus after the company announced a multi year research collaboration with Lausanne University Hospital to study cancer diagnostics using its single cell and spatial platforms. See our latest analysis for 10x Genomics. The Lausanne collaboration lands at a moment when 10x Genomics has been in sharp focus, with the share price at US$47.27 and a 30 day share price return of 21.05% feeding into a 90 day share price return of 110.74% and a 1 year total shareholder...

In July 2026, First Merchants Corporation reported second-quarter and first-half results showing higher net interest income, with US$158.94 million for the quarter and US$310.24 million for the six months, compared with the prior year. Despite this revenue-related improvement, net income and earnings per share from continuing operations fell for both periods, highlighting pressure on overall profitability even as the bank’s core lending engine expanded. We’ll now examine how this mix of...

Over the last 7 days, the United States market has remained flat, yet it is up 18% over the past year with earnings projected to grow by 16% annually in the coming years. In this environment, identifying stocks that are trading below their fair value can present opportunities for investors looking to capitalize on potential growth while minimizing risk.

Over the last 7 days, the United States market has remained flat, yet it has experienced an impressive 18% rise over the past year, with earnings forecasted to grow by 16% annually. In such a climate, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.

The market remained flat over the last week, yet it is up 18% over the past year, with earnings forecast to grow by 16% annually. Investing in penny stocks—often smaller or newer companies—can still open doors to growth opportunities, particularly when these stocks are backed by strong financial health. This article explores several penny stocks that offer compelling opportunities with less risk than one might expect, showcasing above-average balance sheet resilience.

The United States market remained flat over the last week, but it has risen 18% over the past year with earnings forecasted to grow by 16% annually. In this environment, identifying strong dividend stocks can be an effective strategy for investors seeking stable income and potential capital appreciation.

With inflation still running above the Fed’s 2% target and rate expectations shifting with every new comment from policymakers, many investors are rethinking how to position their portfolios. Defensive sector stocks can sometimes offer a steadier ride when interest rates and bond yields are in focus, because these companies sell essential goods and services that people tend to keep buying. This article looks at three U.S. defensive stocks that are closely exposed to the latest Federal Reserve...

The latest round of Section 301 and Section 338 tariffs is prompting investors to reconsider how exposed portfolios are to complex global supply chains. Higher duties, extra compliance checks and uncertain trade rules can all squeeze margins or re-route production closer to home. That is where a curated US manufacturing and onshoring screener can help focus attention. It filters for larger, financially healthy companies with operations rooted in North America. In this article, you will see...

TriMas Corporation’s recent second-quarter and six-month 2026 results showed slightly higher sales of US$174.58 million and US$342.86 million respectively, alongside lower quarterly net income of US$13.37 million but a very large six‑month net income of US$814.2 million, while continuing its share repurchase program and affirming a US$0.0400 quarterly dividend. Beneath the headline numbers, the combination of improved profitability from continuing operations, a long-running buyback that has...

Capitol Federal Financial, Inc. recently reported third-quarter 2026 results, including US$53.48 million in net interest income, US$23.57 million in net income, minimal net charge-offs of US$148,000, completion of a 9,976,478-share buyback totaling US$72.84 million, and reaffirmed a US$0.085 quarterly dividend per share. Together, higher net interest income, growing net income and the completed share repurchase program underscore management’s clear emphasis on capital return and operating...

MetroCity Bankshares earnings trigger fresh interest MetroCity Bankshares (MCBS) has drawn investor attention after reporting second quarter 2026 results, with net interest income of $44.04 million and net income of $22.13 million, both higher than the prior year period. See our latest analysis for MetroCity Bankshares. MetroCity Bankshares has seen mixed trading around the earnings release, with the share price slipping 4.09% over the past month but still posting a 34.68% year to date share...

Eton Pharmaceuticals (ETON) has filed a Prior Approval Supplement with the U.S. Food and Drug Administration to expand KHINDIVI’s label to younger pediatric patients, following bioequivalence data versus ALKINDI SPRINKLE hydrocortisone granules. See our latest analysis for Eton Pharmaceuticals. The KHINDIVI label expansion filing comes after a very strong run in Eton Pharmaceuticals’ stock, with a 30 day share price return of 26.73%, a 90 day share price return of 60.62% and a year to date...

In late July 2026, Myriad Genetics reported second-quarter results showing revenue of US$190.7 million versus US$213.1 million a year earlier, alongside a reduced full-year 2026 revenue outlook of US$770 million to US$790 million due to weaker Prenatal Health test volumes and more cautious assumptions for revenue per test. Despite the revenue decline, the company’s net loss narrowed sharply to US$43.2 million from a very large loss a year ago, highlighting significant cost or non-operational...